2026年以来,诺和诺德、武田、默克等多家跨国药企相继完成中国区“换帅”。费森尤斯卡比中国宣布张巍3月2日加入,4月3日起任总裁兼董事长,她拥有超二十年医药行业经验;罗杰仁2月1日起任默克中国总裁,1月1日起兼任默克生命科学中国负责人,在医药健康和生命科学领域经验丰富;穆安德2月1日起任默克中国医药健康业务董事总经理,他是内部提拔晋升而来;诺和诺德中国宣布周霞萍3月31日离任,蔡琰同日接任大中国区...
Source Link2026年以来,诺和诺德、武田、默克等多家跨国药企相继完成中国区“换帅”。费森尤斯卡比中国宣布张巍3月2日加入,4月3日起任总裁兼董事长,她拥有超二十年医药行业经验;罗杰仁2月1日起任默克中国总裁,1月1日起兼任默克生命科学中国负责人,在医药健康和生命科学领域经验丰富;穆安德2月1日起任默克中国医药健康业务董事总经理,他是内部提拔晋升而来;诺和诺德中国宣布周霞萍3月31日离任,蔡琰同日接任大中国区...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.